Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329:1045-1046 (30 October), doi:10.1136/bmj.329.7473.1045-c
| The first 150 words of the full text of this article appear below. |
EDITORWe have followed with interest the debate about tumour seeding in the aftermath of fine needle aspiration cytology (FNAC) in patients with potentially resectable hepatic colorectal liver metastases.1 The verdict of Metcalfe et al of "useless and dangerous" seems to have provoked strong emotions among some of your readers, and we should like to contribute two observations.
Our staging protocol comprises liver specific magnetic resonance imaging, chest tomography, and the selective use of positron emission tomography, laparoscopy, or a "trial of time," but excluding biopsy. Since 1986 we have undertaken more than 1000 liver resections for metastatic cancer without resort to preoperative biopsy or FNAC, with only seven false positives. In two patients, hepatic cysts were diagnosed at operation and resection was deferred, whereas liver resection was undertaken without complication in the other five (three haemangiomas and two cysts).
A recent analysis of 598 consecutive patients undergoing radical
Oliver M Jones, specialist registrar in surgery
North Hampshire Hospital, Basingstoke RG24 9NA
Myrddin Rees, consultant hepatobiliary surgeon
myrddinrees@btconnect.com, North Hampshire Hospital, Basingstoke RG24 9NA
Tim G John, consultant hepatobiliary surgeon, Sean Bygrave, statistician, Graham Plant, consultant interventional radiologist
North Hampshire Hospital, Basingstoke RG24 9NA